REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 434 filers reported holding REPLIGEN CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $365,723 | +3.4% | 2,300 | -8.0% | 0.05% | +11.6% |
| Q2 2023 | $353,650 | -16.0% | 2,500 | 0.0% | 0.04% | -15.7% |
| Q1 2023 | $420,900 | -0.6% | 2,500 | 0.0% | 0.05% | 0.0% |
| Q4 2022 | $423,275 | -9.6% | 2,500 | 0.0% | 0.05% | -54.1% |
| Q3 2022 | $468,000 | +15.3% | 2,500 | 0.0% | 0.11% | +122.0% |
| Q2 2022 | $406,000 | -13.6% | 2,500 | 0.0% | 0.05% | -2.0% |
| Q1 2022 | $470,000 | -29.0% | 2,500 | 0.0% | 0.05% | -40.0% |
| Q4 2021 | $662,000 | -8.3% | 2,500 | 0.0% | 0.08% | -14.1% |
| Q3 2021 | $722,000 | +14.8% | 2,500 | -20.6% | 0.10% | +30.3% |
| Q2 2021 | $629,000 | +2.8% | 3,150 | 0.0% | 0.08% | +31.0% |
| Q1 2021 | $612,000 | +8.3% | 3,150 | +6.8% | 0.06% | -23.7% |
| Q4 2020 | $565,000 | +25.6% | 2,950 | -3.3% | 0.08% | +7.0% |
| Q3 2020 | $450,000 | – | 3,050 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |